Open-access Failure of neutrophil migration toward infectious focus in severe sepsis: a critical event for the outcome of this syndrome

Abstract

Sepsis is a systemic inflammatory response commonly caused by bacterial infection. We demonstrated that the outcome of sepsis induced by cecal ligation and puncture (CLP) correlates with the severity of the neutrophil migration failure towards infectious focus. Failure appears to be due to a decrease in the rolling and adhesion of neutrophil to endothelium cells. It seems that neutrophil migration impairment is mediated by the circulating inflammatory cytokines, such as TNF-alpha and IL-8, which induce the nitric oxide (NO) production systemically. It is supported by the fact that intravenous administration of these cytokines reduces the neutrophil migration induced by different inflammatory stimuli, and in severe sepsis the circulating concentrations of the cytokines and chemokines are significantly increased. Moreover, the neutrophil migration failure and the reduction in the rolling/adhesion were not observed in iNOS-/- mice and, aminoguanidine prevented this event. We also demonstrated that the failure of neutrophil migration is a Toll-4 receptor (TLR4) dependent mechanism, since it was not observed in TLR4 deficient mice. Furthermore, it was also observed that circulating neutrophils obtained from septic patients present failure of neutrophil chemotaxis toward fMLP, IL-8, and LTB4 and an increased in sera concentrations of NO3 and cytokines. In conclusion, we demonstrated that, in sepsis, failure of neutrophil migration is critical for the outcome and that NO is involved in the process.

sepsis; neutrophil migration; nitric oxide


Failure of neutrophil migration toward infectious focus in severe sepsis: a critical event for the outcome of this syndrome

José Carlos Alves-FilhoI; Claudia BenjamimI; Beatriz Martins Tavares-MurtaII; Fernando Q CunhaI,*

IDepartamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, USP, 14049-900 Ribeirão Preto, SP, Brasil

IIDepartamento Ciências Biológicas, Faculdade de Medicina do Triângulo Mineiro, Uberaba, MG, Brasil

ABSTRACT

Sepsis is a systemic inflammatory response commonly caused by bacterial infection. We demonstrated that the outcome of sepsis induced by cecal ligation and puncture (CLP) correlates with the severity of the neutrophil migration failure towards infectious focus. Failure appears to be due to a decrease in the rolling and adhesion of neutrophil to endothelium cells. It seems that neutrophil migration impairment is mediated by the circulating inflammatory cytokines, such as TNF-a and IL-8, which induce the nitric oxide (NO) production systemically. It is supported by the fact that intravenous administration of these cytokines reduces the neutrophil migration induced by different inflammatory stimuli, and in severe sepsis the circulating concentrations of the cytokines and chemokines are significantly increased. Moreover, the neutrophil migration failure and the reduction in the rolling/adhesion were not observed in iNOS-/- mice and, aminoguanidine prevented this event. We also demonstrated that the failure of neutrophil migration is a Toll-4 receptor (TLR4) dependent mechanism, since it was not observed in TLR4 deficient mice. Furthermore, it was also observed that circulating neutrophils obtained from septic patients present failure of neutrophil chemotaxis toward fMLP, IL-8, and LTB4 and an increased in sera concentrations of NO3 and cytokines. In conclusion, we demonstrated that, in sepsis, failure of neutrophil migration is critical for the outcome and that NO is involved in the process.

Key words: sepsis - neutrophil migration - nitric oxide

Sepsis continues to be one of the most important challenges of modern medicine. Despite many efforts of surgical management, modern antibiotic therapy and intensive care, this disease is the major cause of morbidity and mortality in critically ill patients. In the United States more than 500,000 patients per year develop sepsis with mortality reported between 30 and 70%. Moreover, the costs of treatment have been calculated to amount of more than U$15 billion per year (Angus & Wax 2001, Riedemann et al. 2003).

Sepsis describes a host inability to limit bacterial spread during an ongoing infection, consequently developing a systemic inflammatory response. It is a complex clinical syndrome characterized by severe hypotension and hyporeactivity to vasoconstrictor agents, often associated with multiple organ failure. Significant complications from sepsis include central nervous system dysfunction, adult respiratory distress syndrome, liver failure, acute renal failure and disseminated intravascular coagulation (Bone 1996, Schrier & Wang 2004). For this reason, the host response toward the pathogens must be under strict regulation because the consequences of uncontrolled inflammation can be more fatal than the original inciting pathogens.

During the onset of infection, a complex cascade of events is initiated after the invasion of the host by pathogenic microorganisms (Medzhitov & Janeway 2000). In this context, the neutrophils display a crucial role in orchestrating the host defense. They are the first cells that migrate to an infectious site and are able to kill microorganisms by releasing bactericidal agents like reactive oxygen and nitrogen species. In addiction, these cells also release cytokines and chemokines which enhance the recruitment and activation of themselves and other immune cells (Yamashiro et al. 2001). Therefore, neutrophil recruitment to the infection focus is extremely important for the local control of bacterial growth and consequently for the prevention of bacterial dissemination. In fact, the importance of this phenomenon in the evolution of sepsis has been clearly demonstrated in experimental sepsis in our laboratory. As shown in Fig. 1, mice subjected to lethal sepsis induced by cecal ligation and puncture (CLP) model present impaired neutrophil migration to sites of infection. This impaired neutrophil migration was associated with fail of bacterial clearance in the infectious focus, since we observed increased number of bacteria in peritoneal exudate and blood and high mortality. Conversely, in mice subjected to sub-lethal sepsis, the neutrophil migration was not suppressed and the bacterial infection was restricted to the peritoneal cavity, consequently no mortality was observed (Benjamim et al. 2000). In subsequent study, similar impairment of neutrophil migration with consequent fail to clear bacteria from the infectious focus was observed in lethal sepsis induced by Staphylococcus aureus inoculation (Crosara-Alberto et al. 2002). Altogether, these data provide evidence that the outcome of severely septic animals is correlated with failure of neutrophil migration to the infection site.


The mechanism involved in the impairment of neutrophil migration is still elusive, but it may be due to excessive release of proinflammatory chemokines/cytokines and a concomitant increase in nitric oxide (NO) derived from inducible NO synthase (iNOS). This notion is favored by the following observations that the concentrations of circulating cytokines and chemokines are significantly increased in mice subjected to lethal sepsis when compared with animals subjected to sub-lethal sepsis (Benjamim et al. 2000, 2002, Crosara-Alberto et al. 2002) and intravenous administration of TNF-a and IL-8 inhibited neutrophil migration induced by different inflammatory stimuli (Otsuka et al. 1990, Hechtman et al. 1991,Tavares-Murta et al. 1998). Moreover, the neutrophil migration impairment and reduction of rolling/adhesion found in lethal sepsis induced by CLP were not observed in iNOS-deficient mice or in animals treated with aminoguanidine, a selective iNOS inhibitor (Fig. 2). Thus, overproduction of cytokines, chemokines and NO might be critical events that result in impaired neutrophil migration to sites of infection observed during lethal sepsis induced by microbial infections.


It seems that during an infection, the reaction of immune cells toward pathogens is initiated by toll-like receptors (TLR) which act as sensors of the pathogen-associated molecular patterns (PAMPs), recognizing them as danger signals and triggering the host defense (Medzhitov & Janeway 2000). To date, the TLR family consists of 10 members (TLR1-TLR10). The TLR4 recognizes endotoxin (LPS) of gram-negative bacteria, whereas the TLR2 recognizes different toxins from gram-positive bacteria such as lipoteichoic acid (LTA) and macrophage-activating lipopeptide-2 (MALP-2) (Barton & Medzhitov 2002, Takeda et al. 2003). The role of TLR in response to infection is complex, they are essential components of the innate immune response to infection, but a growing body of evidence indicates that these receptors also may play a role in the pathophysiology of sepsis (Williams et al. 2003, Ishii & Akira 2004, Meng et al. 2004). In this context, recently we investigated the potential role of TLR4 on development of neutrophil migration impairment in polymicrobial sepsis induced by CLP. We observed that TLR4-deficient mice (C3H/HeJ) subjected to lethal sepsis did not present failure of neutrophil migration and this deficiency renders mice more resistant to the lethal effects of sepsis (Fig. 3). This observation suggests that TLR4 signaling is involved in the impairment of neutrophil migration to the infectious focus during lethal sepsis induced by CLP, leading to high mortality.


In humans impairment of neutrophil migration has also been described in cancer (Lejeune et al. 1996), diabetes (Pereira et al. 1987) and AIDS (Mastroianni et al. 1999), all of which are diseases associated with a high susceptibility to infection. In patients infected with human immunodeficiency virus-1, the functional improvement of neutrophil chemotaxis has been found to reduce the incidence and ameliorate the severity of opportunistic infections (Mastroianni et al. 1999). Considering that marked impairment of neutrophil migration is observed in experimental models of sepsis, which is crucial to disease outcome, we also investigated the in vitro chemotactic function of neutrophils from septic patients. We found that the chemotactic responses to FMLP or LTB4 stimuli were suppressed in neutrophils from septic patients compared with healthy controls (Fig. 4). Furthermore, we found that the impairment of neutrophil chemotaxis occurred mainly in neutrophils obtained from nonsurvivor patients (Tavares-Murta et al. 2002). These results, at least to our knowledge, were the first to demonstrate that the outcome of sepsis could be related to the grade of neutrophil chemotactic capacity, pointing to a potential mechanism for the observed reduced host response in septic patients.


The role of the inflammatory response in the pathogenesis of sepsis appears at first contradictory, since both deficient and excessive immune responses appear to be involved (Volk et al. 1996). Inflammatory responses are advantageous for the eradication of bacteria, as long as they are under control. However, once out of control, deregulated inflammation leads to massive production of proinflammatory cytokines. Exaggerated production of cytokines leads to coagulation disorder, tissue injury and finally multiple organ failure, the clinical hallmark of sepsis. Many efforts have been made to improve the understanding of the deregulation of the host response resulting in sepsis. Here, we have provided compelling evidence that the outcome for severity of sepsis is correlated with failure of neutrophil migration to the infection site. We have demonstrated that high concentration of cytokines and chemokines in the circulation with consequent production of NO might be critical events that result in this impaired neutrophil migration. However, it is still unclear the source of these circulating cytokines and chemokines, i.e., if they are produced into the local infectious focus and leak to the circulation, or the bacteria and/or their byproduct leak from the infectious focus to the circulation and stimulate the production of the cytokines systemically.

Received 8 November 2004

Accepted 30 December 2004

Financial support: Fapesp, Capes, CNPq, Pronex

References

  • Angus DC, Wax RS 2001. Epidemiology of sepsis: an update. Crit Care Med 29: S109-116.
  • Barton GM, Medzhitov R 2002. Toll-like receptors and their ligands. Curr Top Microbiol Immunol 270: 81-92.
  • Benjamim CF, Ferreira SH, Cunha FQ 2000. Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis 182: 214-223.
  • Benjamim CF, Silva JS, Fortes ZB, Oliveira MA, Ferreira SH, Cunha FQ 2002. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect Immun 70: 3602-3610.
  • Bone RC 1996. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125: 680-687.
  • Crosara-Alberto DP, Darini AL, Inoue RY, Silva JS, Ferreira SH, Cunha FQ 2002. Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus. Br J Pharmacol 136: 645-658.
  • Hechtman DH, Cybulsky MI, Fuchs HJ, Baker JB, Gimbrone Jr MA 1991. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 147: 883-892.
  • Ishii KJ, Akira S 2004. Toll-like receptors and sepsis. Curr Infect Dis Rep 6: 361-366.
  • Lejeune M, Sariban E, Cantinieaux B, Ferster A, Devalck C, Fondu P 1996. Defective polymorphonuclear leukocyte functions in children receiving chemotherapy for cancer are partially restored by recombinant human granulocyte colony-stimulating factor in vitro. J Infect Dis 174: 800-805.
  • Mastroianni CM, Lichtner M, Mengoni F, D'Agostino C, Forcina G, d'Ettorre G, Santopadre P, Vullo V 1999. Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients. Aids 13: 883-890.
  • Medzhitov R , Janeway Jr C 2000. Innate immune recognition: mechanisms and pathways. Immunol Rev 173: 89-97.
  • Meng G, Rutz M, Schiemann M, Metzger J, Grabiec A, Schwandner R, Luppa PB, Ebel F, Busch DH, Bauer S, Wagner H, Kirschning CJ 2004. Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest 113: 1473-1481.
  • Otsuka Y, Nagano K, Hori K, Oh-ishi J, Hayashi H, Watanabe N, Niitsu Y 1990. Inhibition of neutrophil migration by tumor necrosis factor. Ex vivo and in vivo studies in comparison with in vitro effect. J Immunol 145: 2639-2643.
  • Pereira MA, Sannomiya P, Leme JG 1987. Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetic rat plasma. Diabetes 36: 1307-1314.
  • Riedemann NC, Guo RF, Ward PA 2003. The enigma of sepsis. J Clin Invest 112: 460-467.
  • Schrier RW, Wang W 2004. Acute renal failure and sepsis. N Engl J Med 351: 159-169.
  • Takeda K, Kaisho T, Akira S 2003. Toll-like receptors. Annu Rev Immunol 21: 335-376.
  • Tavares-Murta BM, Cunha FQ, Ferreira SH 1998. The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production. Br J Pharmacol 124: 1369-1374.
  • Tavares-Murta BM, Zaparoli M, Ferreira RB, Silva-Vergara ML, Oliveira CH, Murta EF, Ferreira SH, Cunha FQ 2002. Failure of neutrophil chemotactic function in septic patients. Crit Care Med 30: 1056-1061.
  • Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Muller JM, Docke WD, Kox WJ 1996. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22 (Suppl. 4): S474-481.
  • Williams DL, Ha T, Li C, Kalbfleisch JH, Schweitzer J, Vogt W, Browder IW 2003. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 31: 1808-1818.
  • Yamashiro S, Kamohara H, Wang JM, Yang D, Gong WH, Yoshimura T 2001. Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses. J Leukoc Biol 69: 698-704.
  • *
    Corresponding author. E-mail:
  • Publication Dates

    • Publication in this collection
      14 June 2005
    • Date of issue
      Mar 2005

    History

    • Accepted
      30 Dec 2004
    • Received
      08 Nov 2004
    location_on
    Instituto Oswaldo Cruz, Ministério da Saúde Av. Brasil, 4365 - Pavilhão Mourisco, Manguinhos, 21040-900 Rio de Janeiro RJ Brazil, Tel.: (55 21) 2562-1222, Fax: (55 21) 2562 1220 - Rio de Janeiro - RJ - Brazil
    E-mail: memorias@fiocruz.br
    rss_feed Stay informed of issues for this journal through your RSS reader
    Accessibility / Report Error